Business
Currency:CNY
2024/H1
Stock NameRevenueRatio
于某一时间点确认的收入-销售医药产品94.84M71.15%
于某一时间点确认的收入-许可收入20.68M15.51%
随时间确认的收入-CDMO服务17.77M13.33%
Product
No Data
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
China112.61M84.49%
Overseas20.68M15.51%